by Ket Patel | Jun 21, 2012 | All Articles For Neurology, Neuro-Oncology
Cancer survivors with chemotherapy-induced peripheral neuropathy may be headed for a fall, researchers cautioned at the annual meeting of the American Society of Clinical Oncology. About 12% of patients with chemotherapy-induced peripheral neuropathy (CIPN) had at...
by Ket Patel | Jun 19, 2012 | All Articles For Neurology, Alzheimer's Disease
Approximately one in eight Alzheimer’s disease patients who develop delirium while hospitalized will suffer at least one adverse outcome, based on data from 771 adults. The findings were published in Annals of Internal Medicine on June 18. Previous studies have shown...
by Ket Patel | Jun 19, 2012 | All Articles For Psychiatry, Sleep Disorders
Consistently short sleep duration not only leaves otherwise healthy individuals tired, it also increases their risk of developing stroke, a study has shown. Previous studies have linked self-reported sleep duration to incident stroke, but none have considered whether...
by Ket Patel | Jun 15, 2012 | All Articles For Psychiatry, Depression
A sustained-release formulation of the investigational drug levomilnacipran was found superior to placebo for improving depressive symptoms in adults with major depressive disorder. The randomized, double-blind phase III trial included more than 700 patients....
by Ket Patel | Jun 14, 2012 | All Videos For Neurology, Neuro-Oncology
The antidepressant duloxetine reduces chronic pain from chemotherapy-induced peripheral neuropathy with fewer side effects than with current therapies, according to results of a phase III, double-blind trial. Among evaluable patients, 59% reported less pain with...
